Conformis, Inc. (CFMS) Financial Statements (2024 and earlier)

Company Profile

Business Address 600 TECHNOLOGY DRIVE
BILLERICA, MA 01821
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:48,667100,55628,67326,40023,60045,200
Cash and cash equivalents48,667100,55628,67326,39416,38018,348
Short-term investments     7,24526,880
Other undisclosed cash, cash equivalents, and short-term investments   6(25)(28)
Receivables9,7739,0798,51511,06613,24413,200
Inventory, net of allowances, customer advances and progress billings18,91015,20412,58512,0749,5349,184
Inventory18,91015,20412,58512,0749,5349,184
Other undisclosed current assets1,9192,0443,5712,9741,5782,274
Total current assets:79,269126,88353,34452,51447,95669,858
Noncurrent Assets
Operating lease, right-of-use asset6,0787,5365,215 
Property, plant and equipment8,15410,26812,24013,35614,43916,514
Intangible assets, net (including goodwill)     1096,941
Goodwill      6,731
Intangible assets, net (excluding goodwill)     109210
Restricted cash and investments     462462
Other noncurrent assets85922392111723
Other undisclosed noncurrent assets4625624626,315  
Total noncurrent assets:14,77918,45818,15619,88215,02723,940
TOTAL ASSETS:94,048145,34171,50072,39662,98393,798
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities12,14116,13312,13114,05511,37512,611
Accounts payable4,1636,5574,9186,9203,4454,891
Accrued liabilities7,9789,5767,2137,1357,9307,720
Deferred revenue   14,000 
Debt   1,620   
Deferred revenue and credits305
Contract with customer, liability2,331 
Other undisclosed current liabilities1,9321,8303,1681,469  
Total current liabilities:14,07317,96330,91917,85511,37512,916
Noncurrent Liabilities
Long-term debt and lease obligation20,56326,82629,20919,62314,79229,667
Long-term debt, excluding current maturities20,56320,35525,00319,62314,79229,667
Liabilities, other than long-term debt5,233  13,5006164,665
Deferred revenue and credits4,014
Contract with customer, liability12,000 
Other liabilities230  1,500616651
Operating lease, liability5,0036,4714,206 
Other undisclosed noncurrent liabilities  (6,471) 5,071 37
Total noncurrent liabilities:25,79626,82629,20938,19415,40834,369
Total liabilities:39,86944,78960,12856,04926,78347,285
Equity
Equity, attributable to parent54,179100,55211,37216,34736,20046,513
Common stock  2111 
Additional paid in capital634,647632,513543,809521,356513,336486,570
Accumulated other comprehensive income (loss)856(1,112)(4,000)(865)(1,470)(3,236)
Accumulated deficit(581,324)(530,851)(528,438)(504,145)(475,667)(436,821)
Total equity:54,179100,55211,37216,34736,20046,513
TOTAL LIABILITIES AND EQUITY:94,048145,34171,50072,39662,98393,798

Income Statement (P&L) ($ in thousands)

6/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues62,05099,86068,76177,42989,78978,115
Revenue, net78,115
Cost of revenue(38,837)(34,179)(35,046)(40,692)(41,304)(49,301)
Gross profit:23,21365,68133,71536,73748,48528,814
Operating expenses(69,491)(68,689)(58,829)(61,866)(87,177)(84,661)
Operating loss:(46,278)(3,008)(25,114)(25,129)(38,692)(55,847)
Nonoperating income (expense)(2,199)(3,070)3,236(362)(1,256)4,548
Investment income, nonoperating539776330659491
Gain (loss), foreign currency transaction, before tax(2,252)(3,167)3,160(692)(1,915)4,057
Interest and debt expense(2,019)(3,496)(2,373)(2,942)(3,356)(2,119)
Loss from continuing operations before equity method investments, income taxes:(50,496)(9,574)(24,251)(28,433)(43,304)(53,418)
Other undisclosed income (loss) from continuing operations before income taxes 7,252    
Loss from continuing operations before income taxes:(50,496)(2,322)(24,251)(28,433)(43,304)(53,418)
Income tax expense (benefit)23(91)(42)(45)(61)(162)
Loss from continuing operations:(50,473)(2,413)(24,293)(28,478)(43,365)(53,580)
Loss before gain (loss) on sale of properties:(2,413)(24,293)(28,478)(43,365)(53,580)
Net loss available to common stockholders, diluted:(50,473)(2,413)(24,293)(28,478)(43,365)(53,580)

Comprehensive Income ($ in thousands)

6/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(50,473)(2,413)(24,293)(28,478)(43,365)(53,580)
Comprehensive loss:(50,473)(2,413)(24,293)(28,478)(43,365)(53,580)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent1,9682,888(3,135)6051,766(3,735)
Comprehensive income (loss), net of tax, attributable to parent:(48,505)475(27,428)(27,873)(41,599)(57,315)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: